ascopubs.org

CemiplimAb-rwlc survivorship and epidemiology (CASE): A prospective study of safety and efficacy of cemiplimab in patients with advanced basal cell carcinoma in a real-world ...

PLUME: A single-arm phase II trial evaluating the combination of pembrolizumab and lenvatinib in metastatic uveal melanoma (mUM) patients (pts) previously treated or not with tebentafusp. This is an ...
ascopubs.org

CemiplimAb-rwlc survivorship and epidemiology (CASE): Interim results from a prospective study of the safety and effectiveness of cemiplimab in patients with advanced cutaneous ...

Resistance to anti-PD-1 immunotherapy for stage III and IV melanoma: Results from a global multi-site chart review. This is an ASCO Meeting Abstract from the 2025 ASCO Annual Meeting I. This abstract ...
Frontiers

One Health Workforce Training and Outbreak Response

The increasing frequency of emerging and re-emerging infectious diseases—driven by environmental change, globalisation, and intensified human–animal ...
Frontiers

Geographic Epidemiology of Microbial Diseases: New Insights and Considerations

The emergence of microbial diseases poses a significant threat to public health and welfare worldwide. The spread of these diseases can be endemic (continuous occurrence), epidemic (increased ...